{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:40:55Z","timestamp":1760532055015,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473151"],"award-info":[{"award-number":["81473151"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejps.2021.106042","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T03:44:18Z","timestamp":1634269458000},"page":"106042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Influence of release rate, dose and co-administration on pharmacokinetics, pharmacodynamics and PK-PD relationship of tanshinone IIA and tanshinol"],"prefix":"10.1016","volume":"168","author":[{"given":"Zhenghua","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2021.106042_bib0001","first-page":"571","article-title":"Pharmacodynamic aspects of modes of drug administrationfor optimization of drug therapy","volume":"16","author":"Amnon Hoffman","year":"1999","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejps.2021.106042_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105364","article-title":"Prospective therapeutic potential of Tanshinone IIA: an updated overview","volume":"164","author":"Ansari","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejps.2021.106042_bib0003","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jjcc.2009.05.003","article-title":"Endothelial dysfunction, increased carotid artery intima-media thickness and pulse wave velocity, and increased level of inflammatory markers are associated with variant angina","volume":"54","author":"Cho","year":"2009","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ejps.2021.106042_bib0004","doi-asserted-by":"crossref","first-page":"34","DOI":"10.18433\/J3GP53","article-title":"Understanding the hysteresis loop conundrum in pharmacokinetic \/pharmacodynamic relationships","volume":"17","author":"Christopher Louizos","year":"2014","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.106042_bib0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1753944710396538","article-title":"Salvianolic acid B and Tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways","volume":"5","author":"Chunshui Pan","year":"2011","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.ejps.2021.106042_bib0006","doi-asserted-by":"crossref","unstructured":"Du, G., Zhang, J., 2015. Overview of modern research on danshen. 3\u201317.","DOI":"10.1007\/978-94-017-9463-3_1"},{"key":"10.1016\/j.ejps.2021.106042_bib0007","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF00427897","article-title":"Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam","volume":"86","author":"Ellinwood","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejps.2021.106042_bib0008","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bcp.2013.09.007","article-title":"Pharmacokinetics","volume":"87","author":"Fan","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2021.106042_bib0009","doi-asserted-by":"crossref","first-page":"10161","DOI":"10.18632\/oncotarget.14328","article-title":"Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C\/Wnt signaling pathway","volume":"8","author":"Feng Jun","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejps.2021.106042_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10928-020-09725-w","article-title":"Detection and impact of hysteresis when evaluating a drug's QTc effect using concentration-QTc analysis","volume":"48","author":"Ferber","year":"2021","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejps.2021.106042_bib0011","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00003088-199426020-00006","article-title":"Influence of drug formulation on drug concentration-effect relationships","volume":"26","author":"Gilberto Castaneda-Hernandez","year":"1994","journal-title":"Clin. Phannacokinet."},{"key":"10.1016\/j.ejps.2021.106042_bib0012","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/bdd.1935","article-title":"Modeling of the pharmacokinetic\/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects","volume":"36","author":"Hedaya","year":"2015","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2021.106042_bib0013","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0169-409X(98)00027-1","article-title":"Pharmacodynamic aspects of sustained release preparations","volume":"33","author":"Hoffman","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2021.106042_bib0014","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0169-409X(98)00030-1","article-title":"Role of dosage regimen in controlling indirect pharmacodynamic responses","volume":"33","author":"Jogarao","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2021.106042_bib0015","first-page":"137","article-title":"Evaluation of pharmacokinetics and pharmacodynamics relationships for salvianolic acid B micro-porous osmotic pump pellets in angina pectoris rabbit","volume":"9","author":"Kan","year":"2014","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.106042_bib0016","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0169-409X(98)00031-3","article-title":"Pharmacodynamic aspects of drug administration. Tolerance development","volume":"33","author":"Lennart","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2021.106042_bib0017","doi-asserted-by":"crossref","unstructured":"Liu, A., Guo, D., Zhang, J., Sun, J., 2015. In vivo metabolism of danshen and its preparations. 511\u2013583.","DOI":"10.1007\/978-94-017-9463-3_17"},{"key":"10.1016\/j.ejps.2021.106042_bib0018","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/jphp.13070","article-title":"Application of the relationship between pharmacokinetics and pharmacodynamics in drug development and therapeutic equivalence: a PEARRL review","volume":"71","author":"Loisios-Konstantinidis","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2021.106042_bib0019","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.addr.2009.09.006","article-title":"Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic","volume":"61","author":"Maher","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2021.106042_bib0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/7854_2016_36","article-title":"Pharmacokinetic-pharmacodynamic (PKPD) analysis with drug discrimination","volume":"39","author":"Negus","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.ejps.2021.106042_bib0021","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2125.2003.02062.x","article-title":"Modelling the cardiovascular effects of ephedrine","volume":"57","author":"Persky","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2021.106042_bib0022","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.acvd.2018.08.002","article-title":"Vasospastic angina: a literature review of current evidence","volume":"112","author":"Picard","year":"2019","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.ejps.2021.106042_bib0023","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.mpaic.2008.06.002","article-title":"Hysteresis in drug response","volume":"9","author":"Pleuvry","year":"2008","journal-title":"Anaesth. Intensive Care Med."},{"key":"10.1016\/j.ejps.2021.106042_bib0024","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.neuropharm.2012.07.008","article-title":"Lisdexamfetamine and immediate release d-amfetamine - differences in pharmacokinetic\/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activity","volume":"63","author":"Rowley","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejps.2021.106042_bib0025","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1213\/ANE.0000000000004672","article-title":"Influence of an \"electroencephalogram-based\" monitor choice on the delay between the predicted propofol effect-site concentration and the measured drug effect","volume":"131","author":"Sahinovic","year":"2020","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejps.2021.106042_bib0026","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1538\/expanim.16-0035","article-title":"High susceptibility of atherosclerotic coronary arteries to the onset of vasospasm and angina pectoris-like symptoms due to coronary spasm in WHHLMI rabbits","volume":"65","author":"Tomonari KoiKe","year":"2016","journal-title":"Exp. Anim."},{"key":"10.1016\/j.ejps.2021.106042_bib0027","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2165\/00003088-200038060-00004","article-title":"Pharmacokinetic-pharmacodynamic modelling of the antipyretic effect of two oral formulations of ibuprofen","volume":"38","author":"Troc\u00f3niz","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2021.106042_bib0028","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2125.2005.02335.x","article-title":"A predictive model for exemestane pharmacokinetics\/pharmacodynamics incorporating the effect of food and formulation","volume":"59","author":"Valle","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2021.106042_bib0029","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1124\/jpet.302.3.1158","article-title":"Mechanism-based pharmacokinetic-pharmacodynamic modeling of concentration-dependent hysteresis and biphasic electroencephalogram effects of alphaxalone in rats","volume":"302","author":"Visser","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2021.106042_bib0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2125.1998.00802.x","article-title":"The influence of drug input rate on the development of tolerance to frusemide","volume":"46","author":"Wakelkamp","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2021.106042_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2018.12.016","article-title":"Development of sustained-release pellets to modulate the in vivo processes of the main active components of Danshen: a pharmacokinetic and pharmacodynamic evaluation","volume":"58","author":"Wang","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejps.2021.106042_bib0032","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/10543406.2013.859149","article-title":"Test hysteresis in pharmacokinetic\/pharmacodynamic relationship with mixed-effect models: an instrumental model approach","volume":"24","author":"Wang","year":"2014","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.ejps.2021.106042_bib0033","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/01.fjc.0000191289.35182.7e","article-title":"Pharmacokinetic and pharmacodynamic interaction between Irbesartan and hydrochlorothiazide in renal hypertensive dogs","volume":"46","author":"Xiao-Hui Huang","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejps.2021.106042_bib0034","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejps.2015.05.012","article-title":"Tanshinone IIA - loaded pellets developed for angina chronotherapy: deconvolution-based formulation design and optimization, pharmacokinetic and pharmacodynamic evaluation","volume":"76","author":"Yan","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.106042_bib0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1272\/jnms.78.4","article-title":"Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management","volume":"78","author":"Yoshiki Kusama","year":"2011","journal-title":"J. Nippon Med. Sch."},{"key":"10.1016\/j.ejps.2021.106042_bib0036","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/03639045.2017.1291671","article-title":"Tanshinol sustained-release pellets with absorption enhancer: optimization, characterization, pharmacokinetics and pharmacodynamics","volume":"43","author":"Yu","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2021.106042_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172710","article-title":"Therapeutic potentials and mechanisms of the Chinese traditional medicine Danshensu","volume":"864","author":"Zhang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2021.106042_bib0038","unstructured":"Zhong, Y., 2016. Development of hysteresis analysis as a model-independent approach to assess temporal dissociation in pharmacokinetics and pharmacodynamics."},{"key":"10.1016\/j.ejps.2021.106042_bib0039","doi-asserted-by":"crossref","unstructured":"Zhu, X., Fang, L., Du, G., Zhang, R., Wang, D., Xu, J., Wang, X., 2015. Effects of Danshen on the cardiovascular system. 79\u2013127.","DOI":"10.1007\/978-94-017-9463-3_4"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721003444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721003444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:59:49Z","timestamp":1760529589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721003444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":39,"alternative-id":["S0928098721003444"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.106042","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of release rate, dose and co-administration on pharmacokinetics, pharmacodynamics and PK-PD relationship of tanshinone IIA and tanshinol","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.106042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106042"}}